Brilinta misses primary endpoint in SOCRATES trial
23 March 2016 | By Victoria White
The SOCRATES trial evaluated Brilinta (ticagrelor) versus aspirin for the prevention of major vascular events in patients with an acute ischaemic stroke...
List view / Grid view
News
FDA approves Lilly’s Taltz for plaque psoriasis
23 March 2016 | By Victoria White
Taltz (ixekizumab) is intended for adult patients who are candidates for systemic therapy, phototherapy or a combination of both...
Positive results for Praluent in patients undergoing LDL apheresis therapy
23 March 2016 | By Victoria White
Patients who added Praluent to their existing treatment regimen significantly reduced the frequency of their apheresis therapy by 75% compared to placebo....
Phase III study of tivantinib in hepatocellular carcinoma continues
22 March 2016 | By Victoria White
ArQule and Daiichi Sankyo today announced that the independent DMC has determined that the METIV-HCC will continue to its final analysis...
Cherwell introduces new Redipor® prepared media products to support customer needs
22 March 2016 | By Cherwell Laboratories
New 2016 Redipor® price list available on request...
Moberg Pharma announces plans to develop BUPI into Phase III
22 March 2016 | By Victoria White
BUPI is a patent pending lozenge formulation of bupivacaine for pain management in oral mucositis in cancer patients...
Daratumumab and atezolizumab to be evaluated in two studies
22 March 2016 | By Victoria White
The studies will assess the combination of daratumumab and atezolizumab in multiple myeloma and in solid tumour cancer...
Pharmapack Europe integral to anti-counterfeiting efforts
22 March 2016 | By Victoria White
Pharmapack Europe, organised by UBM EMEA, held its most successful event yet at the Paris expo Porte De Versailles on the 10th and 11th of February 2016...
Pfizer announces results from studies of tofacitinib in ulcerative colitis
21 March 2016 | By Victoria White
Results from OCTAVE Induction 1 and 2, evaluating the efficacy and safety of oral tofacitinib in inducing remission in ulcerative colitis, were presented at ECCO...
MSD presents data from Simponi GO-COLITIS trial
21 March 2016 | By Victoria White
GO-COLITIS evaluated the efficacy of Simponi (golimumab) in inducing and maintaining clinical response in patients with moderate to severe ulcerative colitis...
NICE recommends abiraterone for some prostate cancer patients
21 March 2016 | By Victoria White
Professor Paul Workman of The Institute of Cancer Research, which discovered abiraterone, said the recommendation was “a big victory for men"...
Enstilar receives scientific approval in the EU for psoriasis
21 March 2016 | By Victoria White
Enstilar is a topical spray foam treatment for psoriasis that is designed to provide patients with a convenient treatment option that can be easily applied...
NICE recommends Novartis’ heart failure drug, Entresto
21 March 2016 | By Victoria White
The UK’s National Institute for Health and Care Excellence (NICE) has recommended Novartis’ heart failure drug, Entresto (sacubitrial/valsartan).
Positive top-line results from Phase III study of romosozumab in osteoporosis
21 March 2016 | By Victoria White
The study demonstrated a statistically significant increase in bone mineral density at the lumbar spine in men with osteoporosis treated with romosozumab...
Yusen Logistics builds Logistics Center to expand service in Mexico auto market
Yusen Logistics, a leading third-party logistics provider, announced the start of construction of a logistics center near Celaya, Mexico, to meet the growing demands of its domestic and international automotive customers.
